Lipopolysaccharide and hypoxia/ischemia induced IL-2 expression by microglia in neonatal brain

NeuroReport

Volumn 19, Issue 10, 2008, Pages 997-1002

  Girard, Sylvie ^a   Larouche, Annie ^a   Kadhim, Hazim ^c   Rola Pleszczynski, Marek ^b   Gobeil, Fernand ^b   Sébire, Guillaume ^a,b  

^a Department of Pediatrics   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Cerebral palsy; Hypoxia ischemia; Interleukin 2; Lipopolysaccharide; Perinatal brain

Indexed keywords

INTERLEUKIN 2; LIPOPOLYSACCHARIDE; MESSENGER RNA; AIF1 PROTEIN, RAT; CALCIUM BINDING PROTEIN; INTERLEUKIN 2 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN HYPOXIA; BRAIN ISCHEMIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MICROGLIA; NERVE CELL; NERVE CELL NECROSIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; T LYMPHOCYTE; ANIMAL; ANOXIA; BRAIN; CELL CULTURE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LEWIS RAT; MALE; METABOLISM; METHODOLOGY; PATHOLOGY; PREGNANCY; RANDOMIZATION; TIME;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; BRAIN; CALCIUM-BINDING PROTEINS; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; INTERLEUKIN-2; LIPOPOLYSACCHARIDES; MALE; MICROGLIA; PREGNANCY; RANDOM ALLOCATION; RATS; RATS, INBRED LEW; RECEPTORS, INTERLEUKIN-2; RNA, MESSENGER; TIME FACTORS;

EID: 52249123080     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3283036e88     Document Type: Article

References (25)

1. Nelson KB. Can we prevent cerebral palsy? N Engl J Med 2003; 349: 1765-1769.
2. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997; 278:207-211.
3. Leviton A, Dammann O, Durum SK. The adaptive immune response in neonatal cerebral white matter damage. Ann Neurol 2005; 58:821-828.
4. Kadhim H, Tabarki B, De Prez C, Rona A-M, Sébire G. Interleukin-2 in the pathogenesis of perinatal white matter damage. Neurology 2002; 58:1125-1128.
5. Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, et al. TLR signaling tailors immune response in human microglia and astrocytes. J Immunol 2005; 175:4320-4330.
6. Hanisch UK, Quirion R. Interleukin-2 as a neuroregulatory cytokine. Brain Res Rev 1995; 21:246-284.
7. Hanisch UK. Microglia as a source and target of cytokines. Glia 2002; 40:140-155.
8. Prinz M, Van Rossum D, Hanisch UK. Interleukin-2 as a neuroregulatory cytokine. In: Phelps C, Korneva E, editors. Cytokines and the brain. Amsterdam: Elsevier BV; 2008. pp. 145-165.
9. Krasowska-Zoladek A, Banaszewska M, Kraszpulski M, Konat GW. Kinetics of inflammatory response of astrocytes induced by TLR3 and TLR4 ligation. J Neurosci Res 2007; 85:205-212.
10. Hanisch UK, Neuhaus J, Rowe W, Van Rossum D, Möller T, Kettenmann H, et al. Neurotoxic consequences of central long-term administration of interleukin-2 in rats. Neuroscience 1997; 79:799-818.
11. Curatolo L, Valsasina B, Caccia C, Raimondi GL, Orsini G, Bianchetti A. Recombinant human IL-2 is cytotoxic to oligodendrocytes after in vitro self aggregation. Cytokine 1997; 9:734-739.
12. Karp BI, Yang YC, Khorsand M, Wood R, Merigan TC. Multiple cerebral lesions complicating therapy with interleukin-2. Neurology 1996; 47:417-424.
13. Vecht CJ, Keohane C, Menon RS, Henzen-Logmans SC, den Hoe D. Acute fatal leukoencephalopathy after interleukin-2 therapy. N Engl J Med 1990; 323:1146-1147.
14. Ellison D, Merchant RE. Appearance of cytokine-associated central nervous system myelin damage coincides temporally with serum tumor necrosis factor induction after recombinant interleukin-2 infusion in rats. J Neuroimmunol 1991; 33:245-251.
15. Eitan S, Schwartz M. A transglutaminase that converts interleukin-2 into a factor cytotoxic to oligodendrocytes. Science 1993; 261:106-108.
16. Duggan PJ, Maalouf EF, Watts TL, Sullivan MH, Counsell SJ, Allsop J, et al. Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet 2001; 358:1699-1700.
17. Larouche A, Roy M, Kadhim H, Tsanaclis AM, Fortin D, Sébire G. Neuronal injuries induced by perinatal hypoxic-ischemic insults are potentiated by prenatal exposure to lipopolysaccharide: an animal model for perinatally acquired encephalopathy. Dev Neurosci 2005; 27:134-142.
18. Giulian D, Baker TJ. Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 1986; 6:2163-2178.
19. Nelson KB, Grether JK, Dambrosia JM, Walsh E, Kohler S, Satyanarayana G, et al. Neonatal cytokines and cerebral palsy in very preterm infants. Pediatr Res 2003; 53:600-607.
20. Kaukola T, Satyaraj E, Patel DD, Tchernev VT, Grimwade BG, Kingsmore SF, et al. Cerebral palsy is characterized by protein mediators in cord serum. Ann Neurol 2004; 55:186-194.
21. Elovitz MA, Mrinalini C, Sammel MD. Elucidating the early signal transduction pathways leading to fetal brain injury in preterm birth. Pediatr Res 2006; 59:50-55.
22. Eklind S, Mallard C, Leverin AL, Gilland E, Blomgren K, Mattsby-Baltzer I, et al. Bacterial endotoxin sensitizes the immature brain to hypoxicischaemic injury. Eur J Neuroscience 2001; 13:1101-1106.
23. Coumans AB, Middelanis JS, Garnier Y, Vaihinger HM, Leib SL, Von Duering MU, et al. Intracisternal application of endotoxin enhances the susceptibility to subsequent hypoxic-ischemic brain damage in neonatal rats. Pediatr Res 2003; 53:770-775.
24. Labuzek K, Kowalski J, Herman ZS. Chlorpromazine and loxapine reduce interleukin-1beta and interleukin-2 release by rat mixed glial and microglial cell cultures. Eur Neuropsychopharmacol 2005; 15:23-30.
25. Zhai QH, Futrell N, Chen FJ. Gene expression of IL-10 in relationship to TNF-alpha, IL-1beta and IL-2 in the rat brain following middle cerebral artery occlusion. J Neurol Sci 1997; 152:119-124.